CC
HIPO.WS

Clearline Capital’s Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share HIPO.WS Stock Holding History

Clearline Capital’s Portfolio HIPO.WS Stock Details HIPO.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-81,070
Closed -$75K – 180
2021
Q3 		$75K Buy
+81,070
New +$85.2K 0.01% 154

Other funds holding HIPO.WS

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
LCG
Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return

Clearline Capital's HIPO.WS Position: Q4 2021 in Review

Clearline Capital sold out of Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share (HIPO.WS) in Q4 2021, closing a stake of 81,070 shares — an estimated $75K sold.

Clearline Capital first reported a position in HIPO.WS in Q3 2021 and held it in 1 quarter. The position peaked at $75K in Q3 2021. 23 funds tracked by Wall St. Rank hold HIPO.WS as of Q4 2021.

  • Clearline Capital reported no remaining Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position as of Q4 2021 after selling out during the quarter.
  • Clearline Capital sold 81,070 Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share shares in Q4 2021, an estimated $75K.
  • Clearline Capital first reported a position in Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share in Q3 2021 and held it in 1 quarter.
  • Clearline Capital's Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position peaked at $75K in Q3 2021.
  • 23 funds tracked by Wall St. Rank held Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share as of Q4 2021.

Based on Clearline Capital's 13F filing for Q4 2021, filed 14 Feb 2022.